Clinical News

As inflation rises, consumers are beginning to lose confidence in their ability to cover health care expenses.

Collections of oncology drugs in 13 states are being redistributed to patients in need.

Analysts have identifed treatments that may deliver annual sales topping $1 billion over the next 5 years.

Anacaulase-bcdb improves current standard of care for deep partial thickness and/or full thickness thermal burns.

Prevalence of IBD doubled between 1995 and 2016 and exposure to antibiotics may be to blame.

After being FDA approved in 2021, tezepelumab (Tezspire) has been approved again for self-administration.

A study aims to quantify the burden of current childhood asthma in the United States in association with smoke from indoor gas stoves.

The approval makes zanubrutinib available to all patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whether they are newly diagnosed or previously treated.

A new membership program, SmartRx, offers consumers savings on prescriptions, as well as office visits, eye care, vaccines and pet meds.

Rykindo is a bi-weekly long-acting risperidone injection to treat patients with schizophrenia and bipolar 1 in adults.

New approvals include gene therapies, first-in-class drugs, treatments for rare diseases, and cancer, as well as biosimilars.

Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.

Brexafemme is a non-azole oral antifungal now approved to both treat and prevent recurrent yeast infections in women.

Short-term manufacturing problems are happening as the demand for Adderall and other stimulant medications for ADHD have increased. Data from Arrive Health show a marked increase in ADHD medication prescriptions for people in their 30s.

The treatment is approved for preventing recurrent Clostridioides difficile infections.

CSL Behring's gene therapy, called EntranaDez, may be approved later this month. BioMarin, Pfizer, Bayer and Freeline Therapeutics also have gene therapies for hemophilia in development.

Long-acting recombinant replacement factor gets favorable rating from multidisciplinary group. Gene therapy was viewed with some wariness.

The announcement of positive phase 3 results for the investigational Alzheimer’s disease drug comes against a backdrop of Aduhelm flaming out. Both drugs are predicated on the theory that Alzheimer’s is caused by beta-amyloid deposits.

Move comes after FDA give emergency use authorization for bivalent vaccines.

With the evolution of different COVID-19 variants, finding the mean incubation period has become more complex.

Researchers report that half of the online pharmacies are rogue operations that may operate without a license or have other serious shortcomings.

Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.

Opioid use disorder—how can we battle the epidemic of overdoses?

Overall numbers may be lower, but the obese, racial/ethnic minorities, and those without health care access have higher numbers of undiagnosed diabetes

The rule change could save money for millions.

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

The decision comes following reports of 16,000 cases across 75 countries and territories around the world.

Handing out antibiotics for illnesses they weren’t meant for adds to the distress that health care providers feel.

Does your zip code actually impact your health?

Korsuva is approved for treating moderate to severe pruritis associated with chronickidneydisease